Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

DYNAVAX TECHNOLOGIES CORP Director's Dealing 2023

Mar 1, 2023

32130_dirs_2023-03-01_1d9a0629-2320-426a-bd68-3db2fec45571.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DYNAVAX TECHNOLOGIES CORP (DVAX)
CIK: 0001029142
Period of Report: 2023-02-27

Reporting Person: MacDonald Kelly (SVP and CFO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2023-02-27 Common Stock M 5334 Acquired 5334 Direct
2023-02-27 Common Stock F 2975 $10.36 Disposed 2359 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2023-02-27 Restricted Stock Unit $ M 5334 Disposed Common Stock (5334) Direct

Footnotes

F1: Each RSU represents a contingent right to receive one share of common stock. The RSUs vest over three years with 1/3 vesting on each annual anniversary of February 10, 2022

F2: The reporting person is reporting the withholding by Dynavax Technologies Corporation of 2,975 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the delivery of common stock to the reporting person on February 27, 2023.